Move over, Tesla’s CEO Elon Musk. Clinton’s tweet moves markets in a big way.Tesla: +0.5%Biotech index - 3.36%.(Paraphrased) - We are releasing bigger batteries.Clinton:https://twitter.com/HillaryClinton/status/768508732623970304!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs");Clinton is now setting the cross-hairs against Mylan (MYL) regarding EpiPen pricing. Note: I covered this two days ago in the marketplace subscription series yesterday. Twice. Article titles: Mylan: Making Mad Stacks Of Cash Selling EpiPens To Nerds With Peanut AllergiesWhy Valeant And Nintendo Matters To Us $IBB, iShares Biotechnology ETF / 30 There is no doubt the biotech (IBB) sector is on the action list tomorrow.Tomorrow’s moves: 1.Valeant, set to fly higher as it crossed $30 - $32, may get muddled in the Mylan/price hike controversy2.Pfizer, whose stock is not hurting with the biotech pull-back, may run out of luck.3.Fed rate hike looms. Yellen speaks on Friday. Likelihood of September rate hike is remote. December is more likely. Either way, a higher rate will hurt biotech.4.Cry.5.Cry more.6.Do not panic.7.Join this group, because value stocks seek stocks trading at a discount. That “margin of safety” should shield investors from major losses.8.Post your move, below. It is not limited to biotech stocks.